Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qiagen (QGEN) Gains from Investment Securities (2019 - 2020)

Historic Gains from Investment Securities for Qiagen (QGEN) over the last 6 years, with Q1 2025 value amounting to $2.5 million.

  • Qiagen's Gains from Investment Securities changed N/A to $2.5 million in Q1 2025 from the same period last year, while for Sep 2025 it was -$163.6 million, marking a year-over-year decrease of 17985.63%. This contributed to the annual value of $34.2 million for FY2024, which is 5854.7% down from last year.
  • Latest data reveals that Qiagen reported Gains from Investment Securities of $2.5 million as of Q1 2025.
  • Qiagen's 5-year Gains from Investment Securities high stood at $97.9 million for Q4 2022, and its period low was -$166.1 million during Q4 2024.
  • Over the past 4 years, Qiagen's median Gains from Investment Securities value was $6.3 million (recorded in 2024), while the average stood at $5.9 million.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first tumbled by 2008.76% in 2023, then tumbled by 31227.72% in 2024.
  • Qiagen's Gains from Investment Securities (Quarter) stood at $97.9 million in 2022, then dropped by 20.09% to $78.3 million in 2023, then plummeted by 312.28% to -$166.1 million in 2024, then surged by 101.53% to $2.5 million in 2025.
  • Its Gains from Investment Securities was $2.5 million in Q1 2025, compared to -$166.1 million in Q4 2024 and $6.3 million in Q3 2024.